Your browser doesn't support javascript.
loading
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.
Vokes, Everett E; Mornex, Francoise; Sezer, Ahmet; Cheng, Ying; Fang, Jian; Baz, David Vicente; Cil, Timucin; Adjei, Alex A; Ahn, Myung-Ju; Barlesi, Fabrice; Felip, Enriqueta; Garon, Edward B; Audhuy, Francois; Ito, Rena; Sato, Masashi; Eggleton, S Peter; Martin, Claudio Marcelo; Reck, Martin; Robinson, Clifford G; Paz-Ares, Luis.
Afiliación
  • Vokes EE; University of Chicago Medicine and Biological Sciences, Chicago, Illinois.
  • Mornex F; Centre Hospitalier Universitaire, Lyon, France.
  • Sezer A; Baskent University Adana Application and Research Center, Turkey.
  • Cheng Y; Jilin Cancer Hospital, People's Republic of China.
  • Fang J; Beijing Cancer Hospital, People's Republic of China.
  • Baz DV; Hospital Universitario Virgen Macarena, Spain.
  • Cil T; Adana City Hospital, Health and Science University, Adana, Turkey.
  • Adjei AA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Barlesi F; Aix-Marseille University, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Cancer Research Center of Marseille (CRCM), Assistance Publique Hopitaux de Marseille (APHM), Marseille, France; Paris-Saclay University, Gustave Roussy
  • Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), UVic-UCC, IOB-Quiron, Barcelona, Spain.
  • Garon EB; David Geffen School of Medicine at the University of California, Los Angeles (UCLA), Los Angeles, California.
  • Audhuy F; Merck Serono S.A.S. (an affiliate of Merck KGaA, Darmstadt, Germany), Lyon, France.
  • Ito R; Merck Biopharma Co., Ltd., (an affiliate of Merck KGaA, Darmstadt, Germany), Tokyo, Japan.
  • Sato M; Merck Biopharma Co., Ltd., (an affiliate of Merck KGaA, Darmstadt, Germany), Tokyo, Japan.
  • Eggleton SP; Merck Sereno Ltd. Feltham (an affiliate of Merck KGaA, Darmstadt, Germany), Feltham, United Kingdom.
  • Martin CM; Alexander Fleming Institute, Buenos Aires, Argentina.
  • Reck M; Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany.
  • Robinson CG; Washington University in St. Louis School of Medicine, St. Louis, Missouri.
  • Paz-Ares L; Hospital Universitario 12 de Octubre, CNIO-H12o Lung Cancer Unit, Ciberonc, Madrid, Spain; Complutense University, Madrid, Spain. Electronic address: lpazaresr@seom.org.
J Thorac Oncol ; 19(2): 285-296, 2024 02.
Article en En | MEDLINE | ID: mdl-37797733
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Guideline Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos